U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Kaplan Brett (0001778763)
Mailing Address
C/O PREVAIL THERAPEUTICS INC.
430 EAST 29TH STREET, SUITE 940
NEW YORK NY 10016
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Eliem Therapeutics, Inc.
Current Name:Climb Bio, Inc.		 0001768446 2024-08-26 officer: Chief Operating Officer
Compass Therapeutics, Inc. 0001738021 2020-09-10 director
Prevail Therapeutics Inc. 0001714798 2019-06-19 officer: Chief Financial Officer


Items 1 - 13

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2025-01-13   Climb Bio, Inc. 4 A-Award --D 500000.0000 500000.0000 1 0001768446 Stock Option (Right to Buy)
A 2024-08-26   Eliem Therapeutics, Inc. 4 A-Award --D 465000.0000 465000.0000 1 0001768446 Stock Option (Right to Buy)
A 2024-08-26   Eliem Therapeutics, Inc. 4 A-Award --D 77500.0000 77500.0000 2 0001768446 Restricted Stock Units
A 2022-02-18   Compass Therapeutics, Inc. 4 A-Award --D 30000.0000 30000.0000 1 0001738021 Stock Option (Right to Buy)
D 2021-01-22   Prevail Therapeutics Inc. 4 D-Return --D 347004.0000 0.0000 1 0001714798 Stock Option (Right to Buy)
D 2021-01-22   Prevail Therapeutics Inc. 4 D-Return --D 64565.0000 0.0000 2 0001714798 Stock Option (Right to Buy)
D 2021-01-22   Prevail Therapeutics Inc. 4 D-Return --D 95000.0000 0.0000 3 0001714798 Stock Option (Right to Buy)
A 2020-09-10   Compass Therapeutics, Inc. 4 A-Award --D 60000.0000 60000.0000 1 0001738021 Stock Option (Right to Buy)
A 2020-02-19   Prevail Therapeutics Inc. 4 A-Award --D 95000.0000 95000.0000 1 0001714798 Stock Option (Right to Buy)
- -   Prevail Therapeutics Inc. 3 - --D 1 0001714798 Stock Option (Right to Buy)
- -   Prevail Therapeutics Inc. 3 - --D 2 0001714798 Stock Option (Right to Buy)
- -   Compass Therapeutics, Inc. 3 - --- 1 - -
- -   Eliem Therapeutics, Inc. 3 - --- 1 - -

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016